13-6 Biotechnology companies use relatively little debt because their industries tend to be cyclical,
oriented toward research, or subject to huge product liability suits. Utility companies, on the
13-7 EBIT depends on sales and operating costs that generally are not affected by the firm’s use of
financial leverage, because interest is deducted from EBIT. At high debt levels, however, firms
13-8 Expected EPS is generally measured as EPS for the coming years, and we typically do not reflect
in this calculation any bankruptcy-related costs. Also, EPS does not reflect (in a major way) the
13-9 The tax benefits from debt increase linearly, which causes a continuous increase in the firm’s
13–10 With increased competition after the breakup of AT&T, the new AT&T and the seven Bell
operating companies’ business risk increased. With this component of total company risk
13–11 The firm may want to assess the asset investment and financing decisions jointly. For instance,
the highly automated process would require fancy, new equipment (capital intensive) so fixed
costs would be high. A less automated production process, on the other hand, would be labor
intensive, with high variable costs. If sales fell, the process that demands more fixed costs might